healthneutralTislelizumab and Chemo: A Cost-Effective Pair for Advanced Stomach Cancer in ChinaChinaTuesday, December 31, 2024AdvertisementAdvertisementchinaActionsflag contentPoorly writtenDuplicateInappropriateWrong locationBad formattingFalse InformationPotential Copyright/Trademark Violation